Open access
Jul 2026
Miro1-mediated mitochondrial transfer boosts stem cell therapy for muscle atrophy via restoring mitochondrial homeostasis.
Robust evidence is provided supporting Miro1 as a potential target for the treatment of muscle atrophy-related disorders and indicates that Miro1 is a critical driver of MT, and Miro1-enhanced MT confers substantial in vivo therapeutic benefits.
Fangling Zhao, Jin Fu, Linli Gao et al.
· Stem cell research & therape... · 0 citations